EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Polygenic risk scores for LATE‐neuropathologic change: Implications for clinical utility

Jung-Min Pyun, Young Ho Park, Lincoln M P Shade, David W Fardo, SangYun Kim, Kwangsik Nho iD, Alzheimer's Disease Neuroimaging Initiative

Alzheimer's & Dementia · 2026-10 · 22 (10)

DOI: 10.1002/alz.71824 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 30.10.2026. Verfasst von Jung-Min Pyun und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Seoul National University Bundang Hospital and Seoul National University College of Medicine, Seongnam, Republic of Korea. Hauptthemen laut MEDLINE: Alzheimer Disease, TDP-43 Proteinopathies, Brain. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIA NIH HHS, NLM NIH HHS, Alzheimer's Association.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION Limbic‐predominant age‐related TDP‐43 encephalopathy (LATE) exhibits clinical features resembling Alzheimer's disease (AD) and frequently occurs as a co‐pathology, yet there are fewer biomarkers for LATE relative to AD. METHODS We calculated polygenic risk scores for LATE‐neuropathologic change (LATE‐PRS) and performed association analysis with neuropathology ( N = 99) and longitudinal cognitive change rates ( N = 538) in Alzheimer's Disease Neuroimaging Initiative participants aged ≥ 75 years, stratified by amyloid positron emission tomography (PET) positivity status. RESULTS LATE‐PRS was significantly associated with pathologically confirmed LATE (odds ratio = 2.292, P = 0.002), independent of AD pathology. In cognitively impaired individuals, LATE‐PRS was associated with faster executive function decline in PET‐negative individuals (β = –0.002, P = 0.041), and faster memory (β = –0.002, P < 0.001) and executive function (β = –0.001, P = 0.035 ) decline in PET‐positive individuals. In the overall sample, associations were significant only in the PET‐negative individuals. DISCUSSION LATE‐PRS may serve as a potential biomarker for LATE risk and cognitive progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseTDP-43 ProteinopathiesBrainHumansGenetic Risk ScoreFemalePositron-Emission TomographyMaleAgedExecutive FunctionAged, 80 and overDisease ProgressionCognitive DysfunctionNeuropsychological TestsLongitudinal Studies

Stichwörter der Autor:innen

amyloid positron emission tomography statusbiomarkercognitionlimbic‐predominant age‐related TDP‐43 encephalopathypolygenic risk score

Autor:innen und Institutionen

  • Department of Neurology, Seoul National University Bundang Hospital and Seoul National University College of Medicine, Seongnam, Republic of Korea.
  • Department of Biostatistics, College of Public Health, University of Kentucky, Lexington, Kentucky, USA.
  • Department of Radiology and Imaging Sciences, and the Indiana Alzheimer's Disease Research Center, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Center for Computational Biology and Bioinformatics, Indiana University School of Medicine, Indianapolis, Indiana, USA.

ORCID-Profile: Kwangsik Nho

Förderung

  • NIA NIH HHS
  • NLM NIH HHS
  • Alzheimer's Association
  • Korean government (Ministry of Science and ICT
  • NIH
  • National Research Foundation of Korea
  • National Institutes of Health

Zitieren

APA

Pyun, J. M., Park, Y. H., Shade, L. M. P., Fardo, D. W., Kim, S., Nho, K., & Alzheimer's Disease Neuroimaging Initiative (2026). Polygenic risk scores for LATE‐neuropathologic change: Implications for clinical utility. Alzheimer's & Dementia, 22(10). https://doi.org/10.1002/alz.71824

Vancouver

Pyun JM, Park YH, Shade LMP, Fardo DW, Kim S, Nho K, et al. Polygenic risk scores for LATE‐neuropathologic change: Implications for clinical utility. Alzheimer's & Dementia. 2026;22(10). doi:10.1002/alz.71824

BibTeX
@article{Pyun2026,
  author = {Pyun, Jung-Min and Park, Young Ho and Shade, Lincoln M P and Fardo, David W and Kim, SangYun and Nho, Kwangsik and Alzheimer's Disease Neuroimaging Initiative, Alzheimer's Disease Neuroimaging Initiative},
  title = {Polygenic risk scores for LATE‐neuropathologic change: Implications for clinical utility},
  journal = {Alzheimer's & Dementia},
  year = {2026},
  volume = {22},
  number = {10},
  doi = {10.1002/alz.71824}
}
Kostenlos starten →